51 results
Tricuspid valve intervention in complex scenarios - Patient and procedural optimisation
20 Nov 2023 – From PCR London Valves 2023
Watch this session to enhance your knowledge on optimizing patients throughout the entire transcatheter tricuspid valve intervention process— from pre-procedure preparation to post-procedural care. Learn effective strategies for managing immediate and early complications, refine post-procedural treatment plans, and gain insights into future strategies aimed at further...
Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.
Key questions in tricuspid valve intervention - How does the role of the right heart and pulmonary vasculature influence patient selection?
19 Nov 2023 – From PCR London Valves 2023
Explore insights from an 86-year-old female patient's case with TAVR since end-2022 who presented with permanent AF, moderate MR and TR regurgitation, and learn more about right heart catheterisation for patient selection, CT and CMR in tricuspid interventions, criteria for atrial secondary TR, and more!
Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?
19 Nov 2023 – From PCR London Valves 2023
Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...
Atrial functional tricuspid regurgitation: Importance of atrial fibrillation and right atrial remodeling and prognostic significance
18 Jul 2023
- When tricuspid regurgitation “begets” tricuspid regurgitation -
Reviewer
Short-term outcomes of tricuspid edge-to-edge repair in clinical practice – bRIGHT study
12 Jun 2023
The aim of the b-RIGHT study was to assess the safety and performance of T-TEER using the TriClip (Abbott) in a contemporary, real-world setting...
Reviewer
Reviewer
Reviewer
Transcatheter tricuspid valve interventions
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand clinical scenarios associated with tricuspid regurgitation, to learn the state of the art in devices and indications to treat tricuspid regurgitation, and to deepen into the available evidence of outcomes of different therapies for tricuspid regurgitation.
Triluminate trial: how these data impact my practice
In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben, discuss the results of the Triluminate trial with David Adams and Paul Sorajja. Together they comment on the take-home messages presented during the ACC.23/WCC scientific sessions and how this...
Triluminate trial: deep dive into the outcomes
In this video, members of the PCR Tricuspid Focus Group Nicole Karam and Ralph Stephan von Bardeleben talk with David Adams and Paul Sorajja about the first landmark trial in the field of tricuspid valve disease, Triluminate. Together they discuss the results presented during the ACC.23/WCC...
TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation
04 Mar 2023
Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Author
Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitation
26 Dec 2022
Population-based studies show a higher prevalence of significant TR in women and following that in published and ongoing trials on TTVI more women than men were enrolled. However, so far it has not been investigated whether such differences in epidemiology also would affect TTVI outcomes...
Reviewer
Reviewer
Acute kidney injury following tricuspid transcatheter edge-to-edge repair
17 Oct 2022
Although tricuspid regurgitation has for a long time been “the forgotten valve”, recently there has been a rising awareness of the disease with several important studies investigating its pathophysiology and treatment.
Reviewer
Reviewer
1-year outcomes of Cardioband Tricuspid Valve Reconstruction System early feasibility study
10 Oct 2022
Reviewer
Reviewer
First report of outcomes in the TRILUMINATE pivotal clinical trial in patients with severe tricuspid regurgitation
21 Sep 2022
Alex Sticchi provides his take on the TRILUMINATE pivotal trial which was presented by David H. Adams at the TCT Congress 2022.
Author
Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair
21 Jun 2022
As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.
Reviewer
Reviewer
Reviewer
The PCR Tricuspid Focus Group at EuroPCR 2022
02 Jun 2022
During #EuroPCR 2022, Alessandro Sticchi, member of the PCR Tricuspid group, interviewed several speakers on tricuspid interventions.
The role and evolution of imaging in tricuspid interventions
18 May 2022 – From EuroPCR 2022
In this interview, João Cavalcante and Alessandro Sticchi discuss the evolving role and evolution of advanced imaging in tricuspid interventions.
Transcatheter tricuspid valve repair: CLASP TR study one-year results
19 May 2022 – From EuroPCR 2022
Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
One-year results of the Clasp TR Study: Transcatheter treatment of tricuspid regurgitation
22 Mar 2022
Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.
Author
Author
